Find → Understand → Decide
Capecitabine
Discovery priority: LOW · POSSIBLE / INVESTIGATE
Discovery priority ≠ investment recommendation. These are observation labels, not verified canonical products. Buyer qualification: UNKNOWN.
Why investigate?
Why stranded (event context): inadequate public evidence; supply failure
Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established
Company/trial failed before biology? UNKNOWN
Biology implicated: UNCLEAR · Failure context: CMC/OPERATIONS
MODEL INFERENCE · LOW confidence. Explicit asset-linked program event or documented experimental trial arm, stop scope, dated recency and biological cautions; no publication count or buyer-gate input.
Current control: UNKNOWN · Restart: UNKNOWN · Development reuse: UNKNOWN
Next diligence: Confirm present program status and exact product identity, then trace scoped rights/data/CMC and review arm-level human outcomes.
Existing buyer gates
Human Signal: UNKNOWN
Cheap Truth: UNKNOWN
Clean Rights: UNKNOWN
Market Pull: UNKNOWN
No event or publication count supplies missing gate evidence. Existing reviewed opportunities remain in their original records.
Evidence timeline
2025-05-02 · trial:NCT01349088
Registry update date, not proven program-stop date
SOURCE TEXT · Exact source
WITHDRAWN
Trial reason is not attributed to every intervention; comparator/combination context needs review.
Interpretation: inadequate public evidence · AUTO_INFERRED · MEDIUM
Provenance and retrieval scope
{
"hash": "bae6e9b3a6349485917ae593ab3869bb8be947c97dd025db7fef3ed37bb2c160",
"metadata": {
"complete": false,
"content_hash": "12dba2f64d20d48c47f4c2e04478803287ca92675724e452ceace13362b9457a",
"failed": false,
"last_checked": 1790026982.205955,
"last_success": 1790026982.205955,
"live_verified": true,
"scope": "AREA[OverallStatus]WITHDRAWN AND AREA[StartDate]RANGE[2000-01-01,2014-12-31] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)"
},
"path": "protocolSection.armsInterventionsModule.interventions",
"raw_hash": "12dba2f64d20d48c47f4c2e04478803287ca92675724e452ceace13362b9457a",
"raw_path": "research/obz7_sources/12dba2f64d20d48c47f4c2e04478803287ca92675724e452ceace13362b9457a.json",
"request_params": {
"countTotal": "true",
"format": "json",
"pageSize": 100,
"query.term": "AREA[OverallStatus]WITHDRAWN AND AREA[StartDate]RANGE[2000-01-01,2014-12-31] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)",
"sort": "LastUpdatePostDate:desc"
},
"request_url": "https://clinicaltrials.gov/api/v2/studies",
"type": "clinicaltrials",
"url": "https://clinicaltrials.gov/study/NCT01349088"
}2026-07-31 · trial:NCT07057089
Registry update date, not proven program-stop date
SOURCE TEXT · Exact source
Suspended due to lack of drug supply: the manufacturer ceased to provide investigational drug supply.
Trial reason is not attributed to every intervention; comparator/combination context needs review.
Interpretation: supply failure · AUTO_INFERRED · MEDIUM
Provenance and retrieval scope
{
"hash": "b90b8132d6927fa65a8d326b2bd3a474729d2761e1b5855c2938170969334989",
"metadata": {
"complete": false,
"content_hash": "2ca1679dad0f3f17150af6bd4f23c7bb11e653d2dd78fd7c22183dc1902caeed",
"failed": false,
"last_checked": 1790026985.182528,
"last_success": 1790026985.182528,
"live_verified": true,
"scope": "AREA[OverallStatus]SUSPENDED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)"
},
"path": "protocolSection.armsInterventionsModule.interventions",
"raw_hash": "2ca1679dad0f3f17150af6bd4f23c7bb11e653d2dd78fd7c22183dc1902caeed",
"raw_path": "research/obz7_sources/2ca1679dad0f3f17150af6bd4f23c7bb11e653d2dd78fd7c22183dc1902caeed.json",
"request_params": {
"countTotal": "true",
"format": "json",
"pageSize": 100,
"query.term": "AREA[OverallStatus]SUSPENDED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)",
"sort": "LastUpdatePostDate:desc"
},
"request_url": "https://clinicaltrials.gov/api/v2/studies",
"type": "clinicaltrials",
"url": "https://clinicaltrials.gov/study/NCT07057089"
}2026-09-17 · trial:NCT03585465
Registry update date, not proven program-stop date
SOURCE TEXT · Exact source
Analysis conducted on spring 2025, according to the provisional schedule: the results were sufficient to conclude about all endpoints, and the sponsor defined a new end of trial on 27 Dec 2025 (modification approved on CTIS on May 26, 2026).
Trial reason is not attributed to every intervention; comparator/combination context needs review.
Interpretation: inadequate public evidence · AUTO_INFERRED · LOW
Provenance and retrieval scope
{
"hash": "9743ae1c9afc3ede6d481fb35f0a172f84fa4a72731c4a1f3a07c5f3649ce638",
"metadata": {
"complete": false,
"content_hash": "79a6fba92b66700138ae221547e71d5ac170eb0a4445be6331d6b6a474f18df6",
"failed": false,
"last_checked": 1790026980.9308648,
"last_success": 1790026980.9308648,
"live_verified": true,
"scope": "AREA[OverallStatus]TERMINATED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)"
},
"path": "protocolSection.armsInterventionsModule.interventions",
"raw_hash": "79a6fba92b66700138ae221547e71d5ac170eb0a4445be6331d6b6a474f18df6",
"raw_path": "research/obz7_sources/79a6fba92b66700138ae221547e71d5ac170eb0a4445be6331d6b6a474f18df6.json",
"request_params": {
"countTotal": "true",
"format": "json",
"pageSize": 100,
"query.term": "AREA[OverallStatus]TERMINATED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL)",
"sort": "LastUpdatePostDate:desc"
},
"request_url": "https://clinicaltrials.gov/api/v2/studies",
"type": "clinicaltrials",
"url": "https://clinicaltrials.gov/study/NCT03585465"
}Freshness is claim-specific
Fetching an old filing today does not establish current ownership or program status.
pipeline · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
sec · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
rights · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
contact · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
patent_assignment · PARTIAL · Not independently refreshed for current scoped claim · checked UNKNOWN
clinicaltrials · STALE · AREA[OverallStatus]TERMINATED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL) · checked 2026-09-21T21:43:00.930865+00:00
clinicaltrials · STALE · AREA[OverallStatus]WITHDRAWN AND AREA[StartDate]RANGE[2000-01-01,2014-12-31] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL) · checked 2026-09-21T21:43:02.205955+00:00
clinicaltrials · STALE · AREA[OverallStatus]SUSPENDED AND AREA[StartDate]RANGE[2015-01-01,2026-09-21] AND (AREA[InterventionType]DRUG OR AREA[InterventionType]BIOLOGICAL) · checked 2026-09-21T21:43:05.182528+00:00
Registry observations (4)
NCT03585465 · TERMINATED · PHASE1, PHASE2 · Childhood Solid Tumor · Trial sponsor Centre Oscar Lambret
Reported aliases: None. Identity, treatment role and exposure require review.
NCT01349088 · WITHDRAWN · PHASE1, PHASE2 · Breast Cancer; Metastatic Breast Cancer; Stage IV Breast Cancer · Trial sponsor Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Reported aliases: Xeloda. Identity, treatment role and exposure require review.
NCT07057089 · SUSPENDED · PHASE2 · Locally Advanced Rectal Cancer · Trial sponsor Hebei Medical University Fourth Hospital
Reported aliases: None. Identity, treatment role and exposure require review.
NCT01591733 · COMPLETED · PHASE2 · Pancreatic Cancer · Trial sponsor Massachusetts General Hospital
Reported aliases: None. Identity, treatment role and exposure require review.